$INBP 8-K SEC Filings

Filed On	Filing
25 Sep 2026	8-K: Results of Operations and Financial Condition HILLSIDE, NEW JERSEY (September 25, 2026) - Integrated BioPharma, Inc. ((OTCQX: INBP)) (the “Company” or “INBP”) reports its financial results for the quarter and fiscal year ended June 30, 2026.
20 Aug 2026	8-K: Other Events
02 Jul 2026	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement
08 May 2026	8-K: Results of Operations and Financial Condition
15 Apr 2026	8-K: Other Events
18 Feb 2026	8-K: Entry into a Material Definitive Agreement
11 Feb 2026	8-K: Results of Operations and Financial Condition
01 Dec 2025	8-K: Submission of Matters to a Vote of Security Holders
10 Nov 2025	8-K: Results of Operations and Financial Condition
23 Sep 2025	8-K: Results of Operations and Financial Condition
14 May 2025	8-K: Results of Operations and Financial Condition
24 Apr 2025	8-K: Changes in Registrant's Certifying Accountant
21 Apr 2025	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +1 more
13 Feb 2025	8-K: Results of Operations and Financial Condition
02 Dec 2024	8-K: Submission of Matters to a Vote of Security Holders
14 Nov 2024	8-K: Results of Operations and Financial Condition
23 Sep 2024	8-K: Results of Operations and Financial Condition
10 May 2024	8-K: Results of Operations and Financial Condition
12 Feb 2024	8-K: Results of Operations and Financial Condition
27 Nov 2023	8-K: Submission of Matters to a Vote of Security Holders

Comments